Berenberg Bank restated their buy rating on shares of ConvaTec Group (LON:CTEC – Free Report) in a research note published on Tuesday morning, Marketbeat.com reports. Berenberg Bank currently has a GBX 310 ($3.96) price target on the stock.
A number of other equities analysts also recently commented on CTEC. JPMorgan Chase & Co. cut their price objective on shares of ConvaTec Group from GBX 323 ($4.13) to GBX 290 ($3.71) and set an overweight rating for the company in a research report on Wednesday, July 31st. Royal Bank of Canada dropped their target price on shares of ConvaTec Group from GBX 320 ($4.09) to GBX 305 ($3.90) and set an outperform rating for the company in a report on Wednesday, July 31st. Six equities research analysts have rated the stock with a buy rating, According to data from MarketBeat, the company presently has an average rating of Buy and a consensus target price of GBX 302.50 ($3.87).
Read Our Latest Research Report on ConvaTec Group
ConvaTec Group Stock Performance
ConvaTec Group Cuts Dividend
The company also recently announced a dividend, which will be paid on Friday, October 4th. Shareholders of record on Thursday, August 22nd will be issued a $0.02 dividend. The ex-dividend date is Thursday, August 22nd. This represents a yield of 0.56%. ConvaTec Group’s dividend payout ratio (DPR) is 8,333.33%.
About ConvaTec Group
ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns.
Recommended Stories
- Five stocks we like better than ConvaTec Group
- There Are Different Types of Stock To Invest In
- MarketBeat Week in Review – 8/5 – 8/9
- What are earnings reports?
- Cassava Sciences: A Hot Stock to Trade, Invest, or Avoid?
- How to Invest in Small Cap Stocks
- The Cannabis Sector: Profitability Takes Center Stage
Receive News & Ratings for ConvaTec Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConvaTec Group and related companies with MarketBeat.com's FREE daily email newsletter.